Navigation Links
Novel 'on-off switch' mechanism stops cancer in its tracks
Date:9/23/2009

A tiny bit of genetic material with no previously known function may hold the key to stopping the spread of cancer, researchers at Yale School of Medicine and Sichuan University in Chengdu, China report in two papers in the September 7-11 issue of Proceedings of the National Academy of Sciences.

In the papers, Alan Garen of the Department of Molecular Biophysics & Biochemistry at Yale and his colleague Xu Song explain how cancer may overcome an organism's natural "stop sign" for cell division.

During early development, stem cells give rise to other cells that differentiate into all types of tissue. New cell division and proliferation stop as the organism matures. However, cancer can hijack this process and trigger the uncontrolled cell division that produces cancer tumors.

One mechanism that stops cell proliferation is a family of tumor-suppressor proteins (TSP) that bind to and block the function of proto-oncogenes, or genes that have the potential to trigger cancer.

Garen's team working with mice found that an RNA molecule from an area of the genome that does not produce proteins prevents a type of TSP from inactivating these incipient cancer genes. The TSP protein they studied, called PSF, is virtually identical in mice and humans, he said.

The Yale team succeeded in preventing the formation of tumors in mice by either increasing the amount of PSF or decreasing the amount of the non-coding RNA in a cell.

"The tumor cell stops proliferating and the tumor regresses in a mouse model of cancer, suggesting that both procedures could be the basis of a clinical protocol," said Garen, who is a member of Yale Cancer Center.

Garen and his colleagues plan to continue their studies on the mechanism that regulates the amount of PSF-binding RNA in a cell, which they believe is central to the origins of cancer.


'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert

Page: 1

Related biology news :

1. University of Miami receives NIH grant to support novel technology for tissue engineering
2. Novel bacterial strains clear algal toxins from drinking water
3. Novel genetic region identified for childhood asthma in Mexicans
4. Novel polymer could improve protein-based drugs
5. Novel mechanism revealed for increasing recombinant protein yield in tobacco
6. La Jolla Institute discovers novel tumor suppressor
7. Got zinc? New zinc research suggests novel therapeutic targets
8. Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
9. Novel handheld device detects anthrax with outstanding accuracy and reliability
10. International collaboration by scientists culminates in novel ion channels database
11. UC Davis grant zeroes in on novel asthma diagnosis and treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... More than $4.3 million was raised last night ... ). The gala was held at the American Museum of ... and honored Alan Alda and P. ... medicine and the public understanding of science. Since the first ... has raised $40 million for the Laboratory,s research and education ...
(Date:12/2/2016)... ... December 01, 2016 , ... ACEA Biosciences, Inc. announced today ... clinical trials for AC0010 at the World Conference on Lung Cancer 2016, taking place ... on the phase I/II clinical trials for AC0010 in patients with advanced non-small cell ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... DrugDev ... industry-wide collaboration, standardization and a beautiful technology experience. All three tenets were on display ... 100 clinical trial leaders from over 40 sponsor, CRO and site organizations to discuss ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach USD ... the forecast period of 2016 to 2021 dominated by immunohistochemistry (IHC) ... largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... 225 pages, profiling 10 companies and supported with 181 tables and ...
Breaking Biology Technology: